Breaking Barriers - the First Patient in the World Receives Moderna mRNA Trial Infusion for ...

Retrieved on: 2022-06-08 20:33:08

Tags for this article:

Health

Medical specialties

Hepatology

Inborn errors of carbohydrate metabolism

COVID-19 vaccination in the United States

Clinical trials

RNA vaccines

Glycogen storage disease type I

Glycogen storage disease

MRNA vaccine

Moderna COVID-19 vaccine

University of Connecticut Health Center

Loveah Hernandez

Click the tags to see associated articles and topics

Breaking Barriers - the First Patient in the World Receives Moderna mRNA Trial Infusion for .... View article details on hiswai:

Excerpt

Moderna has been researching the use of mRNA for the potential treatment of the metabolic disorder Glycogen Storage Disease Type Ia (GSD-Ia) caused by ...

Article found on: today.uconn.edu

View Original Article